[Monitoring the patient after treatment: angiographic aspects of recurrence and indications for retreatment].
D000792:Angiography / Q000379:methods; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy*; D004396:Coloring Agents; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D007208:Indocyanine Green; D007273:Injections, Intramuscular; D008268:Macular Degeneration / Q000188:drug therapy*; D008991:Monitoring, Physiologic; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D011166:Porphyrins / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D013997:Time Factors; D041623:Tomography, Optical Coherence; D000077362:Verteporfin; D014792:Visual Acuity
D004396:Coloring Agents; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin; D007208:Indocyanine Green
La surveillance du patient après traitement. Aspects angiographiques des récidives et indications des retraitements.